Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department plans to prevent the unlawful prescription of puberty suppressants from GPs based overseas.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The United Kingdom currently recognises prescriptions from countries on an approved list. A prescription from a country not on the list would not be recognised. We will only recognise prescriptions issued by prescribers of equivalent professional status to those eligible to prescribe in the UK.
We would expect all registered pharmacies and pharmacists to meet the regulatory standards set by the General Pharmaceutical Council or the Pharmaceutical Society of Northern Ireland when considering dispensing any lawfully valid prescription.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to reduce the rate of maternity deaths among Black, Asian and minority ethnic women.
Answered by Nadine Dorries
The NHS Long Term Plan outlines plans to reduce health inequalities and address unwarranted variation in maternity care. This work is led by NHS England through the Maternity Transformation Programme. Targeted and enhanced continuity of care from the same midwife, or group of midwives can significantly improve outcomes for women. The NHS Long-Term plan sets out that 75% of black women will receive continuity of carer from midwives by 2024.
Work to reduce health inequalities around maternal mortality rates is being led by Professor Jacqueline Dunkley-Bent OBE, Chief Midwifery Officer. This includes understanding why mortality rates are higher, considering evidence about what will reduce mortality rates and taking action.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the reasons for the higher rate of death in childbirth for Black women.
Answered by Nadine Dorries
The NHS Long Term Plan outlines plans to reduce health inequalities and address unwarranted variation in maternity care. This work is led by NHS England through the Maternity Transformation Programme. Targeted and enhanced continuity of care from the same midwife, or group of midwives can significantly improve outcomes for women. The NHS Long-Term plan sets out that 75% of black women will receive continuity of carer from midwives by 2024.
Work to reduce health inequalities around maternal mortality rates is being led by Professor Jacqueline Dunkley-Bent OBE, Chief Midwifery Officer. This includes understanding why mortality rates are higher, considering evidence about what will reduce mortality rates and taking action.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the terms of reference for the independent review into gender identity services for children and young people will include (a) the relationship between (i) autism spectrum disorder and (ii) sexuality with gender dysphoria, (b) the potential effect of transgender organisations on gender dysphoria and (d) the experience of (A) desisters and (B) detransitioners; and if he will make a statement.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
The terms of reference for the independent review into gender identity services for children and young people are published on the NHS England and NHS Improvement at the following link:
The review will be wide-ranging and will make recommendations in relation to the best clinical approach for individuals with various complex presentations.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of trends in the level of referrals for the Gender Identity Development Service; and if he will make a statement.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
Since 2013 there has been a 500% increase in the number of young people referred to the Gender Identity Development Service (GIDS).
Dr Hilary Cass has been commissioned to carry out a review of the service, exploring how and when young people are referred to the GIDS. This review is expected to report in autumn 2021.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what role he plans local pharmacies to play in delivering the Government’s ambition for widespread national testing for covid-19; and whether he plans to allocate additional funding to the pharmacy sector to ensure that sector's long term sustainability.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
We will use existing testing facilities to meet our testing priorities. This will mean using testing both across National Health Service and Public Health England settings (pillar 1), as well as through pillar 2 tests at drive through, walk in and via home testing groups. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chief Executive of NHS England on funding being made available in the next Comprehensive Spending Review to ensure the economic viability of independent pharmacies.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department through the Chief Executive of NHS England plans to provide (a) £300m required to cover the annual shortfall in costs undertaken by Pharmacy on behalf on the NHS and (b) indexation of future funding to support family pharmacies; and if he will make a statement.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the September 2020 report by EY on independent pharmacies, what assessment he has made of the implications for the primary care network of the rate of closure of independent community pharmacies staying at the rate indicated in that report over the next four years.
Answered by Jo Churchill - Minister of State (Department for Work and Pensions)
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when his Department plans to update the House on its response to the Independent Medicines and Medical Devices Safety Review; what the Government's priorities are for women's health; and if he will make a statement.
Answered by Nadine Dorries
We do not consider it appropriate to commit to a specific timeframe for a response while these recommendations are being considered. While this report was published on 8 July, it took over two years to compile and we therefore consider it vitally important that it is given full consideration.
Supporting women’s health is critical for the health and care system. We know that there are significant differences and inequalities between different groups of women in terms of access to services, experience of services and health outcomes. We are reflecting on the detailed and thorough First Do No Harm Report published by Baroness Cumberlege and what this tells us about priorities for women’s health.